Leukemia and Lymphoma Unit: Our Team
As San Diego’s only academic medical center, we have world-renowned specialists in leukemia, lymphoma, and other cancers of the blood and bone marrow who take advantage of technologies and therapies not available elsewhere in the region.
Your case will be regularly reviewed by multidisciplinary teams that include hemato-pathologists, medical oncologists, bone marrow transplant physicians and other professionals. In addition, our support services will help you manage symptoms, as well as any psychological or social problems that might arise, ranging from concerns about appearance and employment, to talking with a spouse or family member. You’ll also have access to patient and family support groups that meet throughout San Diego County.
Learn more about our physicians:
- Dr. Thomas Kipps is internationally recognized for his contributions to the understanding of immunobiology, cell biology and the molecular genetics of human B cell malignancies, with emphasis on chronic lymphocytic leukemia (CLL). He also discovered a new type of cell that protects leukemia cells, and he is developing a method to deliver a specially modified gene directly into tumor cells in the patient.
- Dr. Catriona Jamieson discovered candidate cancer stem cells involved in the progression of chronic myelogenous leukemia (CML) to acute leukemia, and the molecular events involved in enhancing CML cancer stem cell proliferation and self-renewal. Now, she has devised robust methods to detect cancer stem cells, permitting a comprehensive assessment of novel cancer stem cell diagnostics and therapeutics.
- Dr. John Adamson
- Dr. Sandford Shattil
- Dr. Erin Reid
- Dr. Parag Sanghvi
Depending on diagnosis, patients may also see members of our acclaimed Blood and Marrow Transplant (BMT) team. Our BMT program is the largest in San Diego and a national leader in physician expertise and state-of-the-art treatment. BMT physicians include:
Two of our leukemia specialists — Dr. Thomas Kipps and Dr. Januario Castro — are members of the prestigious CLL Research Consortium, a multi-institutional program project funded by the National Institutes of Health.